$IPX Income Statement | Understand Stock

$IPX

$14.50 +$1.44 (11.03%) Close

Financial Statements

In millions of USD, except per-share amounts

	FY2026 12 months to Jun 30, 2026	FY2025 12 months to Jun 30, 2025	FY2024 12 months to Jun 30, 2024	FY2023 12 months to Jun 30, 2023	FY2022 12 months to Jun 30, 2022
Continuing operations
Research and development costs
Exploration and evaluation expenses
Corporate and administrative expenses
Business development expenses
Share-based payment expenses
Finance income
Finance costs
Cost of listing on reverse acquisition
Other income and expenses
Loss before income tax
Income tax expense
Loss for the year
Loss attributable to shareholders of IperionX Limited

Other comprehensive income
Items that may be reclassified subsequently to profit or loss:
Exchange differences arising on translation into presentation currency
Other comprehensive income (loss) for the year, net of tax
Total comprehensive loss for the year
Total comprehensive loss attributable to shareholders of IperionX Limited

Comments